Tumor regression grade combined with post‐therapy lymph node status: A novel independent prognostic factor for patients treated with neoadjuvant therapy followed by surgery in locally advanced gastroesophageal junction and gastric carcinoma

MLA

Hongyan Yin, et al. “Tumor Regression Grade Combined with Post‐therapy Lymph Node Status: A Novel Independent Prognostic Factor for Patients Treated with Neoadjuvant Therapy Followed by Surgery in Locally Advanced Gastroesophageal Junction and Gastric Carcinoma.” Cancer Medicine, vol. 12, no. 19, Oct. 2023, pp. 19633–43. EBSCOhost, https://doi.org/10.1002/cam4.6597.

APA

Hongyan Yin, Qian Yao, Yi Xie, Dongfeng Niu, Wenya Jiang, Huiying Cao, Xujiao Feng, Yanyan Li, Yilin Li, Xiaotian Zhang, Lin Shen, & Yang Chen. (2023). Tumor regression grade combined with post‐therapy lymph node status: A novel independent prognostic factor for patients treated with neoadjuvant therapy followed by surgery in locally advanced gastroesophageal junction and gastric carcinoma. Cancer Medicine, 12(19), 19633–19643. https://doi.org/10.1002/cam4.6597

Chicago

Hongyan Yin, Qian Yao, Yi Xie, Dongfeng Niu, Wenya Jiang, Huiying Cao, Xujiao Feng, et al. 2023. “Tumor Regression Grade Combined with Post‐therapy Lymph Node Status: A Novel Independent Prognostic Factor for Patients Treated with Neoadjuvant Therapy Followed by Surgery in Locally Advanced Gastroesophageal Junction and Gastric Carcinoma.” Cancer Medicine 12 (19): 19633–43. doi:10.1002/cam4.6597.